Preclinical studies are critical components of the drug development cycle to assess feasibility and safety of drugs. While there are scientific guidelines from the FDA and European Medicines Agency's on the non-clinical testing of medicines, the selection of drug delivery systems within pre-clinical studies, however, is not standardized.
This webinar will discuss the role of delivery systems in preclinical pulmonary and nasal drug study design. We will highlight existing delivery strategies across animal species. The session will then focus on the pros and cons of administration to small animals such as mice and rates. We will present several case studies for intranasal drug delivery utilizing novel insufflators and microsprayers. The benefits of these novel platforms will be discussed as well as strategies for designing these programs.
Key Learning Objectives
- Review drug delivery systems for preclinical studies.
- Discover how to overcome challenges in preclinical studies.
- Evaluate study design and administration in small animals.
- Explore planning for your next preclinical program.
